Transforming the Veterinary Renal Disease Market in 2025: Increasing Pet Ownership Fuels Growth In The Veterinary Renal Disease Market

"What Is the Expected Size and Growth Rate of the Veterinary Renal Disease Market?
The market size for veterinary kidney diseases has seen profound growth recently. It is set to expand from $15.5 billion in 2024 to $16.63 billion in 2025, with a compound annual growth rate (CAGR) of 7.3%. Several factors contributed to this growth during the historical period, including heightened initiatives to increase disease awareness, a shift in consumer preferences towards organic and natural pet food, a rise in pet ownership rates worldwide, regulatory alterations in veterinary medications, and an increased understanding of pet health and nutrition.

The market size for veterinary renal disease is projected to experience robust growth in the coming years, growing to a value of $21.74 billion in 2029 with a Compound Annual Growth Rate (CAGR) of 6.9%. The expansion expected in the forecasting period is a result of the rise of personalized veterinary medicine, the broadening use of telemedicine and remote observation in veterinary care, the increase in veterinary clinical trials and research, the utilization of blockchain technology for supply chain transparency in veterinary products, and the fusion of artificial intelligence and machine learning in veterinary diagnostics. Noteworthy trends in the forecasting period involve the growing demand for veterinary teleconsultations, the increased interest in tailored pet nutrition plans, the upsurge of wearable health tracking devices for pets, the widening of veterinary telemedicine platforms, and the embracing of precision medicine in veterinary oncology.

What Factors Are Fueling Growth in the Veterinary Renal Disease Market?
Veterinary renal disease market growth is projected to be fueled by rising pet ownership. Veterinary renal disease denotes conditions that affect an animal's kidneys, compromising its kidney function and potentially causing symptoms such as augmented thirst, frequent urination, reduced appetite, and weight loss. Factors such as longer pet lifespans, environmental toxin exposure, diet, and hereditary predispositions are contributing to the growth in veterinary renal disease. Treatments generally entail dietary management, medication, and fluid therapy to mitigate symptoms, slow the disease's progression, and enhance the pet's quality of life. Cooper Pet Care, a mobile pet care platform based in the Netherlands, predicts that by October 2022, the European Union, which includes Norway and Switzerland, will have about 145 million pets, an increase of 5 million from the 2021 figure of approximately 140 million. This population is expected to comprise around 66 million dogs and 79 million cats. Therefore, the rise in pet ownership is propelling the expansion of the veterinary renal disease market.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15957&type=smp

Which Leading Companies Are Shaping the Growth of the Veterinary Renal Disease Market?
Major companies operating in the veterinary renal disease market are Bayer HealthCare Animal Health Inc., Nestlé Purina PetCare Company, Zoetis Inc., Boehringer Ingelheim, Covetrus Inc., Elanco Animal Health Incorporated, Hill's Pet Nutrition Inc., IDEXX Laboratories Inc., Ceva Santé Animale S.A., Dechra Pharmaceuticals PLC, Neogen Corporation, Vetoquinol S.A., Norbrook Laboratories Limited, Nutramax Laboratories Veterinary Sciences Inc., Animalcare Group plc, Antech Diagnostics Inc., Kindred Biosciences Inc., Vedco Inc., MSD Animal Health, Clinical Renal Associates, Veterinary Transplant Services Inc., Kibow Biotech Inc., Northwest Renal Clinic

What Are the Major Trends Shaping the Veterinary Renal Disease Market?
Leading veterinary renal disease market players are centred on innovating technical advancements in both treatment and diagnosis, including introducing modern diagnostic tests designed to identify kidney damage even before clinical symptoms show. These diagnostic tests aim for early detection of minute changes in renal function or structure, thereby allowing prompt intervention to avoid escalating to severe stages of renal dysfunction. For example, IDEXX Laboratories Inc., an American company recognised for developing and manufacturing veterinary products and services, unveiled in June 2023 the pioneer veterinary diagnostic test for detecting kidney injury in cats and dogs. The IDEXX Cystatin B Test, as it is called, is formulated to assist veterinarians in pinpointing kidney damage prior to evident changes in kidney functions, resulting ultimately in improved patient results. The IDEXX Cystatin B Test will be incorporated into renal health assessment test panels, delivering critical insights during an estimated two million annual patient visits.

What Are the Key Segments of the Veterinary Renal Disease Market?
The veterinary renal disease market covered in this report is segmented -

1) By Type: Diagnosis, Treatment
2) By Animal Type: Canine, Feline, Bovine, Equine, Other Animal Types
3) By Indication: Renal Failure, Chronic Kidney Disease (CKD), Renal Cystitis, Kidney Stones, Nephritis, Other Indications
4) By Route of Administration: Injectable, Oral
5) By Distribution Channel: Pharmacies, Pet Specialty Stores, E-commerce, Other Distribution Channels

Subsegments:
1) By Diagnosis: Blood Tests, Urine Tests, Imaging, Biopsy
2) By Treatment: Medications, Dialysis, Kidney Transplantation, Fluid Therapy

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/veterinary-renal-disease-global-market-report

Which Region Dominates the Veterinary Renal Disease Market?
North America was the largest region in the veterinary renal disease market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary renal disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

What Is Covered In The Veterinary Renal Disease Global Market Report?

- Market Size Analysis: Analyze the Veterinary Renal Disease Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Veterinary Renal Disease Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Veterinary Renal Disease Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Veterinary Renal Disease Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15957

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.